Chemomab Therapeutics Ltd. (Nasdaq:CMMB)

Health Care/Life Sciences • Biotechnology

CIK 1534248

Company

Chemomab Therapeutics Ltd. operates as a clinical-stage biotech company. It discovers and develops therapeutics for conditions with unmet need that involve Inflammation and fibrosis. The company was founded by Adi Mor on September 22, 2011 and is headquartered in Tel Aviv, Israel.

Address
Kiryat Atidim
Building 7
Tel Aviv, TA 6158002

Employees
20

Stock Info

Close
$1.4000

Day Range
1.3500 - 1.4427

52 Week Range
0.5790 - 2.5500

Average volume
336.91K

Short Interest
29.26K (02/14/25)

% of Float Shorted
0.18%

Market Cap
$26.4M

Revenue
N/A

Net Income
-$24.16M

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$0.8857

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Chairman
Nissim Darvish

Independent Director
Alan C. Moses

Independent Director
Claude Nicaise

Independent Director
Neil Cohen

SEC filings

Date	Form	Event
10 Dec, 2024	EFFECT
2 Dec, 2024	POS AM
29 Nov, 2024	SC 13D/A
21 Nov, 2024	SC 13G
18 Nov, 2024	6-K
15 Nov, 2024	424B5
14 Nov, 2024	6-K
11 Oct, 2024	6-K
16 Sep, 2024	SC 13D/A
12 Sep, 2024	144
9 Sep, 2024	424B3
6 Sep, 2024	EFFECT
4 Sep, 2024	CORRESP
29 Aug, 2024	UPLOAD
23 Aug, 2024	F-3
21 Aug, 2024	6-K
20 Aug, 2024	SC 13G
9 Aug, 2024	D
25 Jul, 2024	6-K
12 Jun, 2024	6-K
9 May, 2024	6-K
8 May, 2024	6-K
3 May, 2024	6-K
28 Mar, 2024	20-F
11 Mar, 2024	SC 13D/A
7 Mar, 2024	6-K
3 Jan, 2024	6-K
15 Nov, 2023	SC 13D/A
9 Nov, 2023	6-K
3 Nov, 2023	EFFECT
1 Nov, 2023	CORRESP
30 Oct, 2023	F-3/A
16 Oct, 2023	F-3
14 Aug, 2023	6-K
8 Aug, 2023	6-K
5 Jul, 2023	4
3 Jul, 2023	6-K
16 Jun, 2023	4
16 Jun, 2023	8-K
5 Jun, 2023	8-K	CEO Change
5 Jun, 2023	3
2 Jun, 2023	RW
19 May, 2023	S-1/A
11 May, 2023	10-Q
11 May, 2023	8-K
23 Mar, 2023	4
23 Mar, 2023	4
23 Mar, 2023	4
23 Mar, 2023	4
22 Mar, 2023	S-1/A
21 Mar, 2023	S-1/A
21 Mar, 2023	ARS
20 Mar, 2023	10-K
22 Feb, 2023	S-1/A
21 Feb, 2023	8-K
21 Feb, 2023	8-K
21 Feb, 2023	S-1/A
13 Jan, 2023	S-1
11 Jan, 2023	8-K
5 Jan, 2023	4
5 Jan, 2023	SC 13D/A
5 Jan, 2023	4
3 Jan, 2023	8-K
29 Nov, 2022	8-K/A
18 Nov, 2022	4
17 Nov, 2022	SC 13D/A
17 Nov, 2022	4
16 Nov, 2022	8-K
15 Nov, 2022	3
14 Nov, 2022	8-K
10 Nov, 2022	10-Q
15 Aug, 2022	S-8
12 Aug, 2022	10-Q
12 Aug, 2022	8-K
21 Jun, 2022	3
21 Jun, 2022	8-K
21 Jun, 2022	4
8 Jun, 2022	8-K
1 Jun, 2022	8-K
31 May, 2022	DEFA14A
25 May, 2022	4
19 May, 2022	4
12 May, 2022	10-Q
12 May, 2022	8-K
28 Apr, 2022	DEF 14A
25 Apr, 2022	424B5
30 Mar, 2022	10-K
21 Mar, 2022	4
21 Mar, 2022	4
15 Mar, 2022	4
15 Mar, 2022	4
14 Mar, 2022	4
9 Mar, 2022	4
9 Mar, 2022	4
9 Mar, 2022	4
9 Mar, 2022	4
9 Mar, 2022	4
9 Mar, 2022	8-K
11 Feb, 2022	8-K
10 Feb, 2022	SC 13G/A
20 Jan, 2022	SC 13D
5 Jan, 2022	DEF 14A
23 Dec, 2021	PRE 14A
16 Dec, 2021	8-K	CEO Change
8 Dec, 2021	4
3 Dec, 2021	8-K
12 Nov, 2021	8-K
12 Nov, 2021	10-Q
12 Nov, 2021	3
12 Nov, 2021	8-K/A
10 Nov, 2021	8-K
8 Nov, 2021	8-K
4 Nov, 2021	3
3 Nov, 2021	8-K
26 Oct, 2021	8-K
25 Oct, 2021	8-K
17 Sep, 2021	DEF 14A
13 Sep, 2021	S-8
3 Sep, 2021	PRE 14A
2 Sep, 2021	8-K	CEO Change
13 Aug, 2021	10-Q
13 Aug, 2021	8-K
22 Jul, 2021	8-K
14 Jun, 2021	DEF 14A
1 Jun, 2021	PRE 14A
17 May, 2021	EFFECT
13 May, 2021	8-K
13 May, 2021	10-Q
12 May, 2021	CORRESP
10 May, 2021	4
5 May, 2021	UPLOAD
30 Apr, 2021	S-3
29 Apr, 2021	424B3
28 Apr, 2021	EFFECT
26 Apr, 2021	CORRESP
23 Apr, 2021	UPLOAD
21 Apr, 2021	4
21 Apr, 2021	4
21 Apr, 2021	4
21 Apr, 2021	4
21 Apr, 2021	4
21 Apr, 2021	4
15 Apr, 2021	S-3
15 Apr, 2021	SC 13D/A
14 Apr, 2021	8-K/A
5 Apr, 2021	8-K
30 Mar, 2021	D
26 Mar, 2021	3
26 Mar, 2021	SC 13G
26 Mar, 2021	SC 13D
26 Mar, 2021	4
25 Mar, 2021	3
25 Mar, 2021	3
25 Mar, 2021	3
25 Mar, 2021	3
25 Mar, 2021	3
25 Mar, 2021	3
25 Mar, 2021	3
25 Mar, 2021	3
19 Mar, 2021	8-K/A
18 Mar, 2021	4
18 Mar, 2021	4
18 Mar, 2021	3
17 Mar, 2021	8-K	CEO Change
12 Mar, 2021	3
12 Mar, 2021	4
11 Mar, 2021	4
11 Mar, 2021	3
11 Mar, 2021	3
10 Mar, 2021	425
10 Mar, 2021	8-K
9 Mar, 2021	10-K
9 Mar, 2021	425
12 Feb, 2021	424B3
10 Feb, 2021	CORRESP
10 Feb, 2021	CORRESP
10 Feb, 2021	EFFECT
10 Feb, 2021	S-4/A
8 Feb, 2021	8-K
8 Feb, 2021	425
2 Feb, 2021	425
15 Jan, 2021	UPLOAD
13 Jan, 2021	S-4
11 Jan, 2021	425
5 Jan, 2021	425

Last update:2025-03-06 13:28:13.193689

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.